NICK TAYLOR

Profile

First Name

: NICK

Middle Name

:

Last Name

: TAYLOR

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

LOCUS BIOSCIENCES, INC.

BARY BAILEY, CHUCK BRAMLAGE, PAUL GAROFOLO, GEOFFREY GLASS, DAVID JOHNSTON, JOSEPH NIXON, DAVID OUSTEROUT, STUART PETERSON

DIRECTOR

SILVER CREEK PHARMACEUTICALS, INC.

MARK AGNE, ROSS BRECKENRIDGE, LAKHMIR CHAWLA, MICHAEL FAIRBANKS, KRIS KUCHENBECKER, JAMES MARKS, JAMES D. MARKS, THOMAS J. MURTAGH, TOM MURTAGH, ULRIK NIELSEN, BIRGIT SCHOEBERL, TIMOTHY THROSBY

EXECUTIVE OFFICER, DIRECTOR

SURGERY CENTER OF WASILLA, LLC

DERYK ANDERSON, D.O., JEANNE DESAUTELS, ADAM ELLISON, M.D., J THOMAS GRISSOM, M.D., CHARLES HAGGERTY, M.D., MATT HEILALA, M.D., GARTH LECHEMINANT, M.D., DAVID MORROW

EXECUTIVE OFFICER

HATCHER PASS SURGERY CENTER, LLC

DAN CRANE, STEPHEN MARKEWICH

EXECUTIVE OFFICER

SURGERY CENTER OF GEORGETOWN, LLC

LANNA DOMANGUE, ROBERT HANSEN, M.D., JOE JEANETTE, M.D., ROBERT JUST, M.D.

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

HOSPITALS AND PHYSICIANS

DECLINE TO DISCLOSE

Equity

2021-12-20

D

HOSPITALS AND PHYSICIANS

DECLINE TO DISCLOSE

Equity

2023-11-01

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2022-09-30

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2022-05-06

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2022-01-31

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2016-12-01

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-01-13

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-01-13